Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia

<div>The construction of a prognostic risk signature related to outcomes of AML patients. (a) Low and high-risk AML patients’ overall survivals were determined by the use of Kaplan-Meier curves. (b) Time-dependent ROC assays of the identified 7-lncRNA risk signature in AML patients.</div>

Disease Markers

fig3

Figure 3

Figure 3: Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia 